Investor Relations

Corporate Profile

Allogene Therapeutics is a clinical stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for cancer. Led by a world-class management team with significant experience in cell therapy, we are developing a pipeline of “off-the-shelf” CAR T cell therapy candidates with the goal of delivering readily available cell therapy faster, more reliably and at greater scale to more patients.

Copyright West LLC. Minimum 15 minutes delayed.

Latest News

News Releases


More events are coming soon.
Print Page
E-mail Alerts
Investor Contacts